Topic: Pfizer Inc.
The chief executive of drug giant Pfizer Inc., Jeffrey Kindler, received a 2009 compensation package valued by The Associated Press at $13.7 million, down 7.6 percent from 2008, as the board reduced the stock awards he received, citing economic pressures. The reduction ...
Early gains in stocks unraveled Wednesday after the Federal Reserve signaled that the economic recovery will be slow. Stocks ended mixed after the Fed's announcement that economic activity has improved in nine of its 12 districts but that the gains are "modest." The report dampened enthusiasm that followed an upbeat report on services industries and more takeover news. The ...
US indexes are up about a third of a percent, possibly driven by a better than expected ISM report on the service sector. The Institute for Supply Management's services gauge reading of 53 was higher than the expected reading of 50.5.
Among gainers today is software firm Novell (NOVL), up 27% on a "casual" buyout offer from 8 ...
Shares of Medivation Inc. plunged Wednesday after the failure of Dimebon, an Alzheimer's drug the company is developing with Pfizer Inc. Medivation stock lost about two-thirds of its value and fell to an annual low Wednesday morning. Before the market opened, Medivation and Pfizer said ...
